EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy

Jiaqi Xing, Wenjuan Lu, Yubing Zhang, Chen Yang, Jikai Yang, Jing Shi, Yanfeng Wang

Theranostics · 01.01.2026 · 16 (3) · 1295-1327

DOI: 10.7150/thno.121977 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 01.01.2026. Verfasst von Jiaqi Xing und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems, Key Laboratory for Biotechnology Drugs of National Health Commission, Key Laborat…. Hauptthemen laut MEDLINE: Prodrugs, Reactive Oxygen Species, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsReactive Oxygen SpeciesNeoplasmsAntineoplastic AgentsHumansAnimalsNanoparticlesTheranostic NanomedicinePhotochemotherapyDrug Delivery Systems

Stichwörter der Autor:innen

ROSnanoparticlesprodrugstumor treatment

Substanzen

ProdrugsReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Drug Delivery and Release Systems, Key Laboratory for Biotechnology Drugs of National Health Commission, Key Laboratory of Rare and Rare Diseases in Shandong Province, School of Pharmacy…
  • Department of Pharmacy (Shandong Key Traditional Chinese Medical Discipline of Clinical Chinese Pharmacy), Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Scienc…

Zitieren

APA

Xing, J., Lu, W., Zhang, Y., Yang, C., Yang, J., Shi, J., & Wang, Y. (2026). Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy. Theranostics, 16(3), 1295-1327. https://doi.org/10.7150/thno.121977

Vancouver

Xing J, Lu W, Zhang Y, Yang C, Yang J, Shi J, et al. Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy. Theranostics. 2026;16(3):1295-1327. doi:10.7150/thno.121977

BibTeX
@article{Xing2026,
  author = {Xing, Jiaqi and Lu, Wenjuan and Zhang, Yubing and Yang, Chen and Yang, Jikai and Shi, Jing and Wang, Yanfeng},
  title = {Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {1295--1327},
  doi = {10.7150/thno.121977}
}
Kostenlos starten →